TissueGene awarded $750000 Maryland Stem Cell Grant for Invossa clinical study – BSA bureau (press release)
BSA bureau (press release) |
TissueGene awarded $750000 Maryland Stem Cell Grant for Invossa clinical study
BSA bureau (press release) Singapore – TissueGene, Inc., a US-based regenerative medicine company, announced that the Maryland Stem Cell Research Fund (MSCRF) has awarded TissueGene a clinical grant for Invossa, the world's first cell and gene therapy for degenerative … |
